Expression of poly-ADP-ribose polymerase (PARP) in endometrial adenocarcinoma: Prognostic potential-Reference-Cited by-同舟云学术

Expression of poly-ADP-ribose polymerase (PARP) in endometrial adenocarcinoma: Prognostic potential

Published:2020-06 Issue:6 Volume:216 Page:152965
ISSN:0344-0338
Container-title:Pathology - Research and Practice
language:en
Short-container-title:Pathology - Research and Practice

Author:

Lawrence Logan M.,Russell Rebecca,Denning Claire E.,Zgheib Nadim Bou,Salisbury Travis,Lirette Seth T.,Valluri Jagan,Claudio Pier Paolo,Denning Krista L.

Funder

Edwards Foundation at the Edwards Comprehensive Cancer Center

Cabell Huntington Hospital, Huntington WV

Mississippi Center for Clinical and Translational Research

National Institute of General Medical Sciences of the National Institutes of Health

Publisher

Elsevier BV

Subject

Cell Biology,Pathology and Forensic Medicine

Reference44 articles.

1. Poly(ADP-ribose) polymerase-2 (PARP-2) is required for efficient base excision DNA repair in association with PARP-1 and XRCC1;Schreiber;J. Biol. Chem.,2002

2. Poly(ADP-ribose): novel functions for an old molecule;Schreiber;Nat. Rev. Mol. Cell Biol.,2006

3. PARP-2 regulates SIRT1 expression and whole-body energy expenditure;Bai;Cell Metab.,2011

4. Hallmarks of cancer: the next generation;Hanahan;Cell,2011

5. PARP-2 regulates cell cycle-related genes through histone deacetylation and methylation independently of poly(ADP-ribosyl)ation;Liang;Biochem. Biophys. Res. Commun.,2013

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Research Progress of PARP Inhibitor Monotherapy and Combination Therapy for Endometrial Cancer;Current Drug Targets;2022-02